Stay updated with the latest developments in medical technology
預告「人類胞外體製劑臨床試驗申請指引」(草案) ...
Regulations Governing Criteria for the Label, Promotion, Advertisement with Deception, Exaggeration, or Medical efficacy...
獨/外泌體夯!業者誇大「抗衰老」等功效 食藥署開罰124件 ...
Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study ...
Taiwan Bioindustry Development Association